Moving closer to a mouse model for hepatitis C

March 2009
Nature Medicine;Mar2009, Vol. 15 Issue 3, p251
Academic Journal
The article provides authors' insights on a mouse model for treating hepatitis C virus (HCV). It notes that to study immune responses and develop vaccines are laborious and unsuitable despite the usefulness of the models. Furthermore, HCV replication is inefficient in mouse cells, although the studies provide key information on a host cell dependence factor. It also states that it would be better and effective if researchers could humanize mouse.


Related Articles

  • Alcohol Induced Hepatic Degeneration in a Hepatitis C Virus Core Protein Transgenic Mouse Model. Dong-Hyung Noh; Eun-Joo Lee; Ah-Young Kim; Eun-Mi Lee; Chang-Woo Min; Kyung-Ku Kang; Myeong-Mi Lee; Sang-Hyeob Kim; Soo-Eun Sung; Meeyul Hwang; Dae-Yeul Yu; Kyu-Shik Jeong // International Journal of Molecular Sciences;Mar2014, Vol. 15 Issue 3, p4126 

    Hepatitis C virus (HCV) has become a major public health issue. It is prevalent in most countries. HCV infection frequently begins without clinical symptoms, before progressing to persistent viremia, chronic hepatitis, cirrhosis and hepatocellular carcinoma (HCC) in the majority of patients (70%...

  • NICE's approval of hepatitis drugs may create cost dilemma.  // PharmacoEconomics & Outcomes News;Nov2015, Vol. 740 Issue 1, p7 

    The article reports that three new drugs approved cost effective by the Great Britain National Institute for Health and Care Excellence (NICE) for the treatment of hepatitis C virus (HCV) including ombitasvir, daclatasvir and ledipasvir.

  • Increase in Muscle Mitochondrial Biogenesis Does Not Prevent Muscle Loss but Increased Tumor Size in a Mouse Model of Acute Cancer-Induced Cachexia. Wang, Xiao; Pickrell, Alicia M.; Zimmers, Teresa A.; Moraes, Carlos T. // PLoS ONE;Mar2012, Vol. 7 Issue 3, p1 

    Cancer-associated cachexia is a complex metabolic condition characterized by the progressive loss of body fat and deterioration of muscle mass. Although the cellular and molecular mechanisms of cachexia are incompletely understood, previous studies have suggested mitochondrial dysfunction in...

  • Splenic CD8+ T cells secrete TGF-β1 to exert suppression in mice with anterior chamber-associated immune deviation. Liqiong Jiang; Hao He; Peizeng Yang; Xiaomin Lin; Hongyan Zhou; Xiangkun Huang // Graefe's Archive of Clinical & Experimental Ophthalmology;Jan2009, Vol. 247 Issue 1, p87 

    Abstract Background  CD8+ regulatory T cells (Treg) have been considered to be involved in a model of ocular-induced tolerance, known as anterior chamber-associated immune deviation (ACAID). The mechanisms of suppression by CD8+ T cells in ACAID remain only poorly understood. TGF-β1 is...

  • Understanding immunosenescence to improve responses to vaccines. Goronzy, Jörg J; Weyand, Cornelia M // Nature Immunology;May2013, Vol. 14 Issue 5, p428 

    In the older adult, the benefits of vaccination to prevent infectious disease are limited, mainly because of the adaptive immune system's inability to generate protective immunity. The age-dependent decrease in immunological competence, often referred to as 'immunosenescence', results from the...

  • A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice. Yang, Zhi-yong; Kong, Wing-pul; Huang, Yue; Roberts, Anjeanette; Murphy, Brian R.; Subbarao, Kanta; Nabel, Gary J. // Nature;4/1/2004, Vol. 428 Issue 6982, p561 

    Public health measures have successfully identified and contained outbreaks of the severe acute respiratory syndrome (SARS) coronavirus (SARS-CoV), but concerns remain over the possibility of future recurrences. Finding a vaccine for this virus therefore remains a high priority. Here, we show...

  • TriVax-HPV: an improved peptide-based therapeutic vaccination strategy against human papillomavirus-induced cancers. Barrios, Kelly; Celis, Esteban // Cancer Immunology, Immunotherapy;Aug2012, Vol. 61 Issue 8, p1307 

    Background: Therapeutic vaccines for cancer are an attractive alternative to conventional therapies, since the later result in serious adverse effects and in most cases are not effective against advanced disease. Human papillomavirus (HPV) is responsible for several malignancies such as cervical...

  • The murine cellular immune response to adenovirus type 5. Müllbacher, A.; Bellett, A. J. D.; Hla, R. T. // Immunology & Cell Biology;Feb1989, Vol. 67 Issue 1, p31 

    We have characterized the cellular immune response to human adenovirus 5 (Ad-5) in mice, as a basis for future study of responses to foreign antigens in recombinant adenoviruses. Primary in vivo lytic effector cells contained both virus immune cytolytic T (Tc) cells and natural killer cells. The...

  • Development of protective immunity to Salmonella, a mucosal pathogen with a systemic agenda. Griffin, A. J.; McSorley, S. J. // Mucosal Immunology (1933-0219);Jul2011, Vol. 4 Issue 4, p371 

    Salmonella infections can cause a range of intestinal and systemic diseases in human and animal hosts. Although some Salmonella serovars initiate a localized intestinal inflammatory response, others use the intestine as a portal of entry to initiate a systemic infection. Considerable progress...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics